Nacl Industries Ltd · NSE:NACLIND
Nacl Industries — Q2 FY2023 Earnings Presentation
46 slides from Nacl Industries's earnings presentation, October 2022
Slide 1: NACL Industries Limited Investor Presentation Q2 FY2023
NACL Industries Limited Investor Presentation | Q2 FY2023
Slide 2: Forward Looking Statement
Forward Looking Statement This presentation may include statements, which may constitute forward-looking statements. All statements that address expectations or projections about the future, including, but not limited to, statements about the strategy for growth, business development, market positio
Slide 3: Operational Highlights
OPERATIONAL HIGHLIGHTS 3 Investor Presentation
Slide 4: Operational Highlights – Q2 & H1 FY23
Operational Highlights – Q2 & H1 FY23 • Record Quarterly Earnings: • Consolidated EBITDA at Rs 5,703 lakhs up 22% YoY • Consolidated Net Profit at Rs 2,989 lakhs, up 23% YoY • Consecutive eleven quarters of YoY revenue growth • Exports contributed 40% of the total revenues during the first half of F
Slide 5: Results Summary
RESULTS SUMMARY 5 Investor Presentation
Slide 6: Result Summary – Q2FY23
Result Summary – Q2FY23 (In ₹ lakhs) Revenue EBITDA* PAT 5,846 56,491 3,001 4,729 44,285 2,524 28% 24% 19% Q2FY22 Q2FY23 Q2FY22 Q2FY23 Q2FY22 Q2FY23 • Growth in revenue enabled EBITDA • Despite cost pressure, profit has • Strong revenue growth aided by growth increased by 19% YoY higher realization
Slide 7: Result Summary – Q2FY23
Result Summary – Q2FY23 (In ₹ lakhs) Revenue Breakup Insecticides 14% Herbicides 8% Q2FY23 Q2FY22 Q2FY23 Q2FY22 20,876 18,276 7,833 7,256 Fungicides 60% Plant Growth Regulators 31% Q2FY23 Q2FY22 Q2FY23 Q2FY22 24,097 15,055 3,434 2,626 7 Investor Presentation
Slide 8: Revenue Split – Q2FY23
Revenue Split – Q2FY23 (In ₹ lakhs) Q2FY23 Q2FY22 Product Category-wise (%) Product Category-wise (%) Formulation Technical Formulation Technical 9% 4% 12% 28% 32% 25% 21% 50% 49% 52% 56% 12% 16% 15% 19% Insecticides Herbicides Fungicides Plant Growth Regulators & others Insecticides Herbicides Fung
Slide 9: Revenue Split – Q2FY23
Revenue Split – Q2FY23 (In ₹ lakhs) Q2FY23 Geographical Revenue Split (₹ lakhs) Q2FY22 Geographical Revenue Split (₹ lakhs) 35, 000 40, 000 7% 35, 000 33,638 14% 30, 000 28,834 4% 30, 000 4% 25, 000 6% 22,853 Exports 25, 000 Exports 20, 000 17% 15,451 15% 20, 000 15, 000 62% 15, 000 67% 3% 10, 000 1
Slide 10: Result Summary – H1 FY23
Result Summary – H1 FY23 (In ₹ lakhs) Revenue EBITDA* PAT 9,480 4,514 1,04,025 7,883 76,753 36% 3,955 20% 14% H1 FY22 H1 FY23 H1 FY22 H1 FY23 H1 FY22 H1 FY23 Insecticides xx% Herbicides xx% Fungicides xx% Plant Growth Regulators xx% Insecticides 18% Herbicides 26% Fungicides 71% Plant Growth Regulat
Slide 11: Revenue Split – H1 FY23
Revenue Split – H1 FY23 (In ₹lakhs) H1 FY23 Product Category-wise (%) H1 FY22 Product Category-wise (%) Formulation Technical Formulation Technical 3% 8% 10% 27% 18% 31% 16% 53% 51% 55% 57% 13% 21% 19% 18% Insecticides Herbicides Fungicides Plant Growth Regulators & others Insecticides Herbicides Fu
Slide 12: Profit and Loss – Q2 & H1 FY23 (Standalone)
Profit and Loss – Q2 & H1 FY23 (Standalone) Particulars (₹ in lakhs) Q2 FY23 Q2 FY22 Y-o-Y Q1 FY23 Q-o-Q H1 FY23 H1 FY22 Y-o-Y Revenue from Operations (Net of Excise) 56,491 44,285 28% 47,534 19% 104,025 76,753 36% Other Income 426 547 293 719 862 Total Income 56,917 44,832 27% 47,827 19% 104,744 77
Slide 13: Profit and Loss – Q2 & H1 FY23 (Consolidated)
Profit and Loss – Q2 & H1 FY23 (Consolidated) Particulars (₹ in lakhs) Q2 FY23 Q2 FY22 Y-o-Y Q1 FY23 Q-o-Q H1 FY23 H1 FY22 Y-o-Y Revenue from Operations (Net of Excise) 56,491 44,285 28% 47,534 19% 104,025 76,753 36% Other Income 283 483 162 445 750 Total Income 56,774 44,768 27% 47,696 19% 104,470
Slide 14: Balance Sheet (1/2)
Balance Sheet (1/2) Standalone Consolidated Particulars (₹ in lakhs) Sep-22 Mar-22 Sep-22 Mar-22 ASSETS Non-current assets (a) Property, plant and equipment 20,011 20,354 20,039 20,381 (b) Right-to-use assets 419 461 3,273 3,331 (c) Capital work-in-progress 1,544 955 18,835 10,456 (d) Other intangib
Slide 15: Balance Sheet (2/2)
Balance Sheet (2/2) Standalone Consolidated Particulars (₹ in lakhs) Sep-22 Mar-22 Sep-22 Mar-22 EQUITY AND LIABILITIES Equity (a) Equity share capital 1,984 1,983 1,984 1,983 (b) Other equity 50,684 46,412 51,093 46,854 Total equity 52,668 48,395 53,077 48,837 Non-current liabilities (a) Financial
Slide 16: Credit Rating
Credit Rating Assigned CRISIL A1 ₹ 204 Crores Short Term Bank Facilities Long Term Bank Facilities ₹ 396 Crores CRISIL A; Stable Assigned 16 Investor Presentation
Slide 17: Corporate Identity
CORPORATE IDENTITY 17 Investor Presentation
Slide 18: About NACL, Mission, Values
About NACL Mission NACL has been an established player • To be a trusted name in providing high quality in the Agrochemical industry since products and solutions to the farming community 1993. The Company started as an Active Ingredient manufacturer and • To be a trusted custom & contract manufactur
Slide 19: Quick Facts
Quick Facts 1,200+ 30 5 Employee Strength Geographical Million Farmers Presence ( Customers ) 3 25+ 63 Manufacturing Years of Branded Products Units Experience 19 Investor Presentation
Slide 20: Geographical Reach
Geographical Reach USA 30 - Countries Uzbekistan 1,200+ - Employees Iran Lebanon Nepal Egypt Taiwan Thailand 35 - Revenue from International (%) Sudan Jordan India Costa Rica Yemen Columbia Uganda Ethiopia Tanzania Sri Lanka Ecuador 03 - Manufacturing Plants Brazil Zambia Paraguay Myanmar Argentina
Slide 21: Product Portfolio (1/2) – Technicals
Product Portfolio (1/2) Technicals Insecticides Fungicides Herbicides • Profenofos • Myclobutanil • Pretilachlor • Lambda-Cyhalothrin • Propiconazole • Bispyribac Sodium • Imidacloprid • Tricyclazole • Metribuzin • Bifenthrin • Thifluzamide • Clodinafop-Propargyl • Thiamethoxam • Difenoconazole • Qu
Slide 22: Product Portfolio (2/2)
Product Portfolio (2/2) Cairo Fenny Nagarjuna 4G Profex Status Trust Cannon Fury Nagarjuna Mida Profex Super Syndicate Warrior Insecticides Dxtar Force Super Nagarjuna Mantle Pymet Task Gr Warrior Plus Dxtar FS Hurricane Plus Nagarjuna Spice Quick 50% SP Task SC Ennova Monocrown Pest Lock Combi plus
Slide 23: Timeline (1/2)
Timeline (1/2) Acquired two Pesticide Commencement of Chemagro International The 3rd Technical The 4th Technical Formulation Plants at Monocrotophos (MCP) Limited became Nagarjuna Manufacturing block Manufacturing block Ethakota in East Godavari commercial production Agrichem Limited and the was est
Slide 24: Timeline (2/2)
Timeline (2/2) State-of-the-Art Co-marketing partnership Bagged “India's Best Company Registered highest Registered highest Research & with leading Japanese of the Year Award – 2017”, by turnover of Rs.1015 ever turnover of Development Center chemical companies for International Brand Consulting cro
Slide 25: Board of Directors
Board of Directors Mrs. K Lakshmi Raju Mr. M Pavan Kumar Mr. C. Varada Rajulu Mr. N Vijayaraghavan Mr. Sudhakar Kudva Mr. Raghavender Mateti Chairperson & Managing Director & Executive Director - Independent Director Independent Director Independent Director Non-Executive Director CEO Corporate Affa
Slide 26: Senior Management Team (1/2)
Senior Management Team (1/2) Mr. M Pavan Kumar Mr. C. Varada Rajulu Mr. G. Jagannadha Rao Mr. R.K.S Prasad Managing Director & CEO Executive Director - President – Executive VP – Corporate Affairs International key accounts Finance & CFO Mr. Amit Taparia Mr. Harish Chandra Bijlwan Mr. Satish Kumar S
Slide 27: Senior Management Team (2/2)
Senior Management Team (2/2) Mr. Seshagiri Rao Mr. Srinivasa Rao Bitra Mr. S. Mani Prasad Dr. Sunil Kumar Singh Vice President- Plant Senior General Manager & Head – Human Potential Head - Research & Operations (Technical Plant) Head - Plant Operations Development Development (Formulations Unit) Dr.
Slide 28: NACL's Business Model
NACL’s Business Model 50+ Branded Products, 47 NACL stock points and Thousands of retail Technical outlets across India manufacturing plant under the Company’s with a production direct to retail capacity of 10,000 approach metric tons per annum A state-of-the-art Formulation unit with Knowledge Deli
Slide 29: Business Strategy
BUSINESS STRATEGY Strengthening and enhancing global collaborations Substantial capacity enhancement strategy in Agrochemical, Specialty Chemicals & Continue to invest in Product Registrations, Advanced Intermediaries Process know –how, Brand building Tap new geographies and Farmer Centric product s
Slide 30: NACL – A Unique Investment Case
NACL – A Unique Investment Case RESEARCH & GOVERNANCE DEVELOPMENT & LEADERSHIP Capable R&D team with Accomplished Board Members state-of-the-art, GLP and seasoned professional CONSISTENT accredited facility, to leadership with decades of GROWTH DISTRIBUTION develop differentiated industry experience
Slide 31: Certificates
Certificates RC certificate GLP certificate DSIR R&D Facility ISO Accreditations NABL Accreditations ISO 45001:2018 ISO 14001:2015 ISO 9001:2015 R&D Facility Ethakota Unit Srikakulam Unit 31 Investor Presentation
Slide 32: Awards and Accolades
Awards and Accolades Greentech Award Suraksha Certificate of Best Management Water Industry Champion ABSA Company of Puraskar Appreciation Award Management Award 2021 the Year Award NACL has bagged Award 2022 the “Greentech NACL’s Srikakulam NACL’s Ethakota NACL’s manufacturing NACL's Srikakulam NAC
Slide 33: Key External Drivers of the Business
Key External Drivers of the Business Indian Agrochemical Market India is the fourth-largest producer of agrochemicals in the world after USA, Japan and China. The Indian agrochemical market are expected to continue to grow between 5% and 6% through 2030.Government has identified the agrochemical ind
Slide 34: Research & Development
Research & Development R&D labs at Shadnagar and Srikakulam are DSIR Development of new generation, environment recognized. Quality Control labs in the above locations and friendly and safe Formulations Ethakota are NABL accredited. Process development of Active Ingredients and Intermediates R&D lab
Slide 35: Production Capacity
Production Capacity Ethakota Unit, AP PRODUCTION CAPACITY 12,000 KL Liquid Formulation 5,600 MT Powder Formulation 35,475 MT Granule Formulation Technical Grade 10,000 MT* *Being expanded to 25,000 MT Srikakulam Unit, AP 35 Investor Presentation
Slide 36: Capacity Expansion Plans
Capacity Expansion Plans Srikakulam Technical Plant BROWNFIELD NACL Industries is in process of increasing Limited, Srikakulam, the capacity from 10,000 PROJECT Andhra Pradesh MT/Annum to 25,000 MT/Annum. GREENFIELD PROJECTS NACL Multichem Private Limited, NACL Spec-Chem Limited, Ranasthalam Mandal,
Slide 37: Green Field Project at Dahej (Gujarat) Nearing Completion
Green Field Project at Dahej (Gujarat) Nearing Completion 37 Investor Presentation
Slide 38: Sustainability – Environment, Health & Safety
Sustainability – Environment, Health & Safety Manufacturing Plants are certified Integrated Management Systems Strong EHS systems, processes, related to quality, environment, inspection and training who health and safety (ISO) with enhance awareness and ensure adequately green belt cover practices S
Slide 39: Shareholder's Information
SHAREHOLDER’S INFORMATION 39 Investor Presentation
Slide 40: Shareholders Information
Shareholders Information Stock Information (as on 25th October, 2022) (As on 30th September 2022) Market Capitalization (₹) 1,733.93 Cr Shareholding Pattern (%) Shares Outstanding 19.83 Cr Free Float 300.76 Cr Symbol (BSE) / (NSE) 524709 / NACLIND Stock Performance Chart (as of October, 2022) 34.16%
Slide 41: Performance Track Record
PERFORMANCE TRACK RECORD 41 Investor Presentation
Slide 42: Historic Quarterly Trend (1/2)
Historic Quarterly Trend (1/2) (₹ in lakhs) Revenue from operations 7,000 EBITDA 60,000 56,491 6,000 5,846 47,534 47,287 50,000 44,285 4,729 5,000 39,976 4,277 40,000 4,259 34,417 33,043 4,000 3,634 32,468 3,565 30,172 3,521 27,663 3,154 30,000 26,475 25,202 2,888 23,868 3,000 2,383 19,099 2,138 20,
Slide 43: Historic Quarterly Trend (2/2)
Historic Quarterly Trend (2/2) (₹ in lakhs) PBT PAT 4,500 3,500 4,012 4,000 3,001 3,000 3,500 3,409 2,524 2,500 3,000 2,921 2,796 2,102 1,869 2,500 2,000 2,041 2,239 2,136 1,714 1,513 1,547 2,000 1,905 1,500 1,431 1,500 1,432 1,000 910 1,025 804 1,000 644 702 536 500 424 500 500 309 143 124 - - Q1 Q
Slide 44: Financial Performance (1/2)
Financial Performance (1/2) (₹ in lakhs) Revenue from Operations EBITDA and EBITDA Margin CAGR 17% CAGR 27% 10.61% 9.49% 18,0 00 12. 00% 16,0 00 7.44% 14,0 00 1,64,016 12,0 00 10,0 00 1,19,137 6.0 0% 12,806 15,725 8,00 0 1,01,489 6,00 0 4,00 0 7,607 2,00 0 - 0.0 0% FY20 FY21 FY22 FY20 FY21 FY22 EBIT
Slide 45: Financial Performance (2/2)
Financial Performance (2/2) (₹ in lakhs) Working Capital Days Net Worth 107 79 82 48,395 41,148 35,053 FY20 FY21 FY22 FY20 FY21 FY22 ROCE and ROE Debt to Equity (x) 22.01% 0.24 20.68% 0.21 13.57% 15.71% 12.22% 0.10 4.50% FY20 FY21 FY22 ROCE ROE FY20 FY21 FY22 45 Investor Presentation
Slide 46: Thank You
NACL Industries Limited Plot No 12-A, C Block, Lakshmi Towers, Nagarjuna Hills, Punjagutta, Hyderabad - 500082, Telangana, India +91-40 -24405100 info@naclind.com https://naclind.com/ S-Ancial Technologies Pvt. Ltd. (Investor Relations) 215, Shivshakti Industrial Estate, J. R. Boricha Marg, Lower Pa